Nationwide use of psychotropic drugs for treatment of self-reported depression in the Brazilian urban adult population

ABSTRACT: Objective: Antidepressant use is increasing worldwide, but national data on psychotropic drug use by depressed patients in Brazil is lacking. Methodology: Between 2013 and 2014, a representative sample of urban adult individuals were asked if they had a diagnosis of chronic disease, had a medical indication for drug treatment, and were taking chronic medications at the time for each reported diagnosis. We analyzed the frequencies of reported depression and the medications related to this disease. Results: Overall, 6.1% of respondents reported depression. The prevalence increased with age - 9.5% among the elders - was higher among women (8.9%) and in the south of the country (8.9%). As a single disease, the prevalence of depression was higher among young people (17.6%). Among those with multimorbidity, the prevalence of depression rose to 25.7%. Of those who reported depression, 81.3% had medical indication for treatment and 90.3% were under treatment - this proportion was lower among young people (84.5%) and those living in the poorest region (78.6%). Antidepressants accounted for 47.2% of psychotropic drugs taken by respondents with depression, with regional differences - only 30% used antidepressants in the North. Polypharmacy was reported by 22% of those with depression and other chronic diseases. Conclusion: Depression in Brazil, is common among young adults as a single chronic disease and highly prevalent among people with chronic multimorbidity, especially the young. The treatment gap was larger among young people and in the less developed regions of the country.

Saved in:
Bibliographic Details
Main Authors: Ramos,Luiz Roberto, Mari,Jair de Jesus, Fontanella,Andréia Turmina, Pizzol,Tatiane da Silva Dal, Bertoldi,Andréa Dâmaso, Mengue,Sotero Serrate
Format: Digital revista
Language:English
Published: Associação Brasileira de Saúde Coletiva 2020
Online Access:http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1415-790X2020000100452
Tags: Add Tag
No Tags, Be the first to tag this record!
id oai:scielo:S1415-790X2020000100452
record_format ojs
spelling oai:scielo:S1415-790X20200001004522020-06-17Nationwide use of psychotropic drugs for treatment of self-reported depression in the Brazilian urban adult populationRamos,Luiz RobertoMari,Jair de JesusFontanella,Andréia TurminaPizzol,Tatiane da Silva DalBertoldi,Andréa DâmasoMengue,Sotero Serrate Population Studies in Public Health Prevalence Chronic diseases Psychotropic drugs Depressive Disorder ABSTRACT: Objective: Antidepressant use is increasing worldwide, but national data on psychotropic drug use by depressed patients in Brazil is lacking. Methodology: Between 2013 and 2014, a representative sample of urban adult individuals were asked if they had a diagnosis of chronic disease, had a medical indication for drug treatment, and were taking chronic medications at the time for each reported diagnosis. We analyzed the frequencies of reported depression and the medications related to this disease. Results: Overall, 6.1% of respondents reported depression. The prevalence increased with age - 9.5% among the elders - was higher among women (8.9%) and in the south of the country (8.9%). As a single disease, the prevalence of depression was higher among young people (17.6%). Among those with multimorbidity, the prevalence of depression rose to 25.7%. Of those who reported depression, 81.3% had medical indication for treatment and 90.3% were under treatment - this proportion was lower among young people (84.5%) and those living in the poorest region (78.6%). Antidepressants accounted for 47.2% of psychotropic drugs taken by respondents with depression, with regional differences - only 30% used antidepressants in the North. Polypharmacy was reported by 22% of those with depression and other chronic diseases. Conclusion: Depression in Brazil, is common among young adults as a single chronic disease and highly prevalent among people with chronic multimorbidity, especially the young. The treatment gap was larger among young people and in the less developed regions of the country.info:eu-repo/semantics/openAccessAssociação Brasileira de Saúde ColetivaRevista Brasileira de Epidemiologia v.23 20202020-01-01info:eu-repo/semantics/articletext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S1415-790X2020000100452en10.1590/1980-549720200059
institution SCIELO
collection OJS
country Brasil
countrycode BR
component Revista
access En linea
databasecode rev-scielo-br
tag revista
region America del Sur
libraryname SciELO
language English
format Digital
author Ramos,Luiz Roberto
Mari,Jair de Jesus
Fontanella,Andréia Turmina
Pizzol,Tatiane da Silva Dal
Bertoldi,Andréa Dâmaso
Mengue,Sotero Serrate
spellingShingle Ramos,Luiz Roberto
Mari,Jair de Jesus
Fontanella,Andréia Turmina
Pizzol,Tatiane da Silva Dal
Bertoldi,Andréa Dâmaso
Mengue,Sotero Serrate
Nationwide use of psychotropic drugs for treatment of self-reported depression in the Brazilian urban adult population
author_facet Ramos,Luiz Roberto
Mari,Jair de Jesus
Fontanella,Andréia Turmina
Pizzol,Tatiane da Silva Dal
Bertoldi,Andréa Dâmaso
Mengue,Sotero Serrate
author_sort Ramos,Luiz Roberto
title Nationwide use of psychotropic drugs for treatment of self-reported depression in the Brazilian urban adult population
title_short Nationwide use of psychotropic drugs for treatment of self-reported depression in the Brazilian urban adult population
title_full Nationwide use of psychotropic drugs for treatment of self-reported depression in the Brazilian urban adult population
title_fullStr Nationwide use of psychotropic drugs for treatment of self-reported depression in the Brazilian urban adult population
title_full_unstemmed Nationwide use of psychotropic drugs for treatment of self-reported depression in the Brazilian urban adult population
title_sort nationwide use of psychotropic drugs for treatment of self-reported depression in the brazilian urban adult population
description ABSTRACT: Objective: Antidepressant use is increasing worldwide, but national data on psychotropic drug use by depressed patients in Brazil is lacking. Methodology: Between 2013 and 2014, a representative sample of urban adult individuals were asked if they had a diagnosis of chronic disease, had a medical indication for drug treatment, and were taking chronic medications at the time for each reported diagnosis. We analyzed the frequencies of reported depression and the medications related to this disease. Results: Overall, 6.1% of respondents reported depression. The prevalence increased with age - 9.5% among the elders - was higher among women (8.9%) and in the south of the country (8.9%). As a single disease, the prevalence of depression was higher among young people (17.6%). Among those with multimorbidity, the prevalence of depression rose to 25.7%. Of those who reported depression, 81.3% had medical indication for treatment and 90.3% were under treatment - this proportion was lower among young people (84.5%) and those living in the poorest region (78.6%). Antidepressants accounted for 47.2% of psychotropic drugs taken by respondents with depression, with regional differences - only 30% used antidepressants in the North. Polypharmacy was reported by 22% of those with depression and other chronic diseases. Conclusion: Depression in Brazil, is common among young adults as a single chronic disease and highly prevalent among people with chronic multimorbidity, especially the young. The treatment gap was larger among young people and in the less developed regions of the country.
publisher Associação Brasileira de Saúde Coletiva
publishDate 2020
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1415-790X2020000100452
work_keys_str_mv AT ramosluizroberto nationwideuseofpsychotropicdrugsfortreatmentofselfreporteddepressioninthebrazilianurbanadultpopulation
AT marijairdejesus nationwideuseofpsychotropicdrugsfortreatmentofselfreporteddepressioninthebrazilianurbanadultpopulation
AT fontanellaandreiaturmina nationwideuseofpsychotropicdrugsfortreatmentofselfreporteddepressioninthebrazilianurbanadultpopulation
AT pizzoltatianedasilvadal nationwideuseofpsychotropicdrugsfortreatmentofselfreporteddepressioninthebrazilianurbanadultpopulation
AT bertoldiandreadamaso nationwideuseofpsychotropicdrugsfortreatmentofselfreporteddepressioninthebrazilianurbanadultpopulation
AT menguesoteroserrate nationwideuseofpsychotropicdrugsfortreatmentofselfreporteddepressioninthebrazilianurbanadultpopulation
_version_ 1756420048503701504